Pathology Testing Services for HFE Genes

Opportunity overview

Betsi Cadwaladr University Health Board intends to award a contract to a provider under the Most Suitable Provider Process for the provision of Pathology Testing Services for HFE Genes including extraction

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

• CPV85111800 — Pathology services
• CPV85111810 — Blood analysis services

Lots

• This is a Provider Selection Regime (PSR) Intention to Award Notice. Betsi Cadwaladr University Health Board (BCUHB) intends to to award a contract under the Most Suitable Provider Process under The Health Services (Provider Selection Regime) (Wales) Regulations 2025 for the provision of outsourced pathology testing services for HFE genes, including sample extraction. In accordance with the Most Suitable Provider Process, the Contracting Authority has considered which providers are capable of delivering the service and, having regard to the key criteria and all relevant information available at this time, considers that it has identified the most suitable provider to deliver the requirement. The Contracting Authority intends to award a single contract to the most suitable provider. This Intention to Award Notice will be published for a period of at least 8 days. Additional information: This is a Provider Selection Regime (PSR) Intention to Award a Contract Notice. The contract is subject to The Health Services (Provider Selection Regime) (Wales) Regulations 2025 and is intended to be awarded using the Most Suitable Provider Process.Value not stated